|Day Low/High||2.47 / 2.57|
|52 Wk Low/High||2.25 / 3.89|
Movers roundup: JC Penney rises on upbeat analyst, improving outlook; Accenture plunges
PDL BioPharma shares rise on revenue outlook, Lazard Capital analyst upgrade
Google, Amgen, Tyson Foods, KB Home, Johnson Controls are among big market movers Friday
Facet Biotech shares rise on positive funding outlook, advancing product pipeline
These heavily shorted NYSE stocks could surge higher on any positive catalyst.
Legg Mason, Discover, Tiffany and VF Corp. are downgraded; PDL Biopharma is upgraded.
Bristol and ImClone shares fall as more drama unfolds surrounding their potential merger. King Pharmaceuticals' shares are down after it increased its bid for Alpharma.
The company's shares were down slightly after it agreed to buy rights to a dairy cow supplement from Monsanto.
The two drugmakers signed a development and commercialization agreement for an early stage prospective treatment for multiple myeloma.
United Airlines' operator's shares are up 8.2% after the company announces new charges for checked bags.
Maxygen slides on news Amgen was granted a patent that may affect Maxygen's MAXY-G34, a possible treatment for chemotherapy-induced neutropenia.
Shares gain 13.6% after The Wall Street Journal reports that the company is developing a new broadband technology.
Shares fall 16% after the company gives guidance below expectations.
The biotech firm plans to sell its antibody manufacturing plant for $240 million.
The biotech firm sells off its cardiovascular assets for a price below expectations.
NYSE Euronext, Wesco Financial and Foundation Coal upgraded; PDL BioPharma and Knight Transport downgraded.
Xoma's apparent lack of interest in a buyout may not serve investors in the near term.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.